A Rooming-in Program to Mitigate the Need to Treat for Opiate Withdrawal in the Newborn

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 5, 2012, Pages 475-481

  Hodgson, Zoë G ^a   Abrahams, Ronald R ^a,b,c  

^a WOMEN S HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Fir; NAS; Neonatal abstinence syndrome; Policy; Postnatal care; Rooming in care; Substance use disorders

Indexed keywords

METHADONE; MORPHINE; NARCOTIC AGENT;

ADULT; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METHADONE TREATMENT; MOTHER CHILD RELATION; NEEDS ASSESSMENT; NEWBORN; NEWBORN INTENSIVE CARE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PERINATAL CARE; RETROSPECTIVE STUDY; ROOMING IN; TREATMENT DURATION; WITHDRAWAL SYNDROME; HEROIN DEPENDENCE; NEWBORN CARE;

ADULT; BREAST FEEDING; HEROIN DEPENDENCE; HUMANS; INFANT, NEWBORN; METHADONE; MORPHINE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; ROOMING-IN CARE; YOUNG ADULT;

EID: 84867594623     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35245-8     Document Type: Article

References (26)

1. Finnegan L.P. Management of pregnant drug-dependent women. Ann NY Acad Sci 1978, 311:135-146.
2. Allen M.H. Detoxification considerations in the medical management of substance abuse in pregnancy. Bull NY Acad Med 1991, 67:270-276.
3. Kaltenbach K., Berghella V., L.Finnegan Opioid dependence during pregnancy. Obstet Gynecol Clin N Am 1998, 25:139-151.
4. Jansson L.M., Svikis D.S., Velez M., Fitzgerald E., H.E.Jones The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse 2007, 42:961-974.
5. Madden J.D., Chappel J.N., Zuspan F., Gumpel J., Mejia A., R.Davis Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 1977, 127:199-201.
6. Jones H.E., O'Grady K.E., Malfi D., M.Tuten Methadone maintenance vsmethadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008, 17:372-386.
7. Dryden C., Young D., Hepburn M., H.Mactier Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009, 116:665-671.
8. Dashe J.S., Sheffield J.S., Olscher D.A., Todd S.J., Jackson G.L., G.D.Wendel Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002, 200:1244-1249.
9. Berghella V., Lim P.J., Hill M.K., Cerpes J., Chennat J., K.Kaltenbach Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 2003, 89:312-317.
10. McCarthy J.J., Leamon M.H., Parr M.S., B.Anania High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 2005, 193:606-610.
11. Seligman N.S., Salva N., Hayes E.J., Dysart K.C., Pequignot E.C., J.K.Baxter Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 2008, 199:396.e1-396.e7.
12. Cleary B.J., Donnelly J.M., Strawbridge J.D., Gallagher P.J., Fahey T., White M.J., et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol 2011, 204:139.e1-139.e9.
13. Cleary B.J., Donnelly J., Strawbridge J., Gallagher P.J., Fahey T., Clarke M., et al. Methadone dose and neonatal abstinence syndrome'systematic review and meta-analysis. Addiction 2010, 105:2071-2084.
14. Thajam D., Atkinson D.E., Sibley C.P., T.Lavender Is neonatal abstinence syndrome related to the amount of opiate used?. J Obstet Gynecol Neonatal Nurs 2010, 39:503-509.
15. Lim S., Prasad M.R., Samuels P., Gardner D.K., L.Cordero High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. Am J Obstet Gynecol 2009, 200:70.e1-70.e5.
16. Abrahams R.R., MacKay-Dunn M.H., Neverjitskaia N., MacRae G.S., Payne S.P., Hodgson Z.G. An evaluation of rooming-in among substanceexposed newborns in British Columbia. J Obstet Gynaecol Can 2010, 32:866-871.
17. García-Algar O. Nicotine withdrawal symptoms in newborns. Arch Bronconeumol 2008, 44:509-511.
18. Pichini S., Garcia-Algar O. In utero exposure to smoking and newborn neurobehavior: how to assess neonatal withdrawal syndrome?. Ther Drug Monit 2006, 28:288-290.
19. Saiki T., Lee S., Hannam S., A.Greenough Neonatal abstinence syndrome- postnatal ward versus neonatal unit management. Eur J Pediatr 2010, 169:95-98.
20. Jansson L.M., Choo R., Velez M.L., Harrow C., Schroeder J.R., Shakleya D.M., et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics 2008, 121:106-114.
21. McCarthy J.J., B.L.Posey Methadone levels in human milk. J Hum Lact 2000, 16:115-120.
22. Begg E.J., Malpas T.J., Hackett L.P., IIett K.F. Distribution of R- and S-methadone into human milk during multiple, medium and high oral dosing. Br J Clin Pharmacol 2001, 52:681-685.
23. Abdel-Latif M.E., Pinner J., Clews S., Cooke F., Lui K., J.Oei Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006, 117:117:1163-117:1169.
24. A.J.W.Liu, N.Ralph Letter to the editor: methadone maintenance and breastfeeding in the neonatal period. Pediatrics 2008, 121:869.
25. Harper R.G., Solish G., Feingold E., Gersten-Woolf N.B., M.M.Sokal Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstet Gynecol 1977, 129:417-424.
26. Sanz E.J., De-las-Cuevas C., Kiuru A., Bate A., R.Edwards Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005, 365:482-487.